Cigna & FTC Settle: Transforming Pharmacy Benefits Management
Cigna's settlement with the FTC on pharmacy benefits reform marks a pivotal moment for compliance and profitability in health insurance. Learn about its impacts and future plans.
GAO Reports ACA Tax Credit Fraud; Medicare Drug Costs, Debt Risks Rise
Recent GAO report reveals ACA Premium Tax Credit fraud. Rising Medicare Part D costs, Social Security debt risks, bond market stability concerns, and congressional stock trading scrutiny highlight U.S. insurance and fiscal challenges.
Understanding IRMAA: Influence on Medicare Premiums for Higher-Income Beneficiaries
Explore how IRMAA impacts Medicare premiums for higher-income beneficiaries and its significance for U.S. healthcare insurance and compliance professionals.
Medicare Part D Reimbursement Changes Threaten Rural Long-Term Care Pharmacies
Medicare Part D reimbursement changes under the Inflation Reduction Act risk destabilizing rural long-term care pharmacies, threatening access to essential pharmaceutical services for seniors. Legislative and CMS actions are needed to mitigate financial impacts.
CMS Proposes 2027 Updates to Medicare Advantage and Part D Policies
CMS issues proposed rule for 2027 Medicare Advantage and Part D, including STAR rating updates, special enrollment flexibilities, and enhanced data access. Comments due Jan 2026.
Smart Medigap Plans Expands Personalized Medicare Consultation Services in Texas
Smart Medigap Plans expands personalized Medicare consultation services in Texas to help beneficiaries navigate complex Medicare supplement and Part D coverage options amid rising enrollment and regulatory changes.
CMS Proposes 2027 Medicare Advantage and Part D Regulatory Updates and Data Use Changes
CMS issues proposed 2027 updates to Medicare Advantage, Part D, risk adjustment, and reporting rules, seeking stakeholder input on quality measures and program improvements.
CMS Medicare Drug Price Negotiations Yield $12B Savings on 15 High-Cost Medications
CMS announces $12 billion savings from Medicare drug price negotiations on 15 high-cost medications, effective 2027, enhancing Medicare Part D sustainability.
Strategies to Manage Medicare Part D Prescription Costs in 2026
Explore key strategies and programs to reduce Medicare Part D prescription medication costs in 2026, including Extra Help, state assistance, generic options, and payment plans.
CMS Proposes Medicare Advantage and Part D Updates to Simplify Star Ratings
CMS proposes 2027 Medicare Advantage and Part D updates to simplify Star Ratings and introduce a depression screening measure. Public comment open for 60 days.